Gemcitabine plus split-dose cisplatin could be a promising alternative to gemcitabine plus carboplatin for cisplatin-unfit patients with advanced urothelial carcinoma
暂无分享,去创建一个
I. Jeong | D. You | H. Ahn | Cheryn Song | Yi Rang Kim | B. Hong | J. Lee | J. Hong | Y. Kim